Suraksha Diagnostic Limited
Suraksha Diagnostic released the transcript for its Q4 and FY26 earnings call. Management discussed robust revenue and EBITDA growth, alongside strategic expansion into new geographies and diagnostic capabilities. The company outlined INR 70 crore capex for FY27 to fund new centers.
May 27 2026 16:09:09
Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Suraksha Diagnostic announced the availability of the audio recording for its Q4 FY26 earnings call, held on May 22, 2026. The recording, which covers audited financial results and other business discussions, can be accessed on the company's website for investors.
May 22 2026 14:36:32
Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suraksha Diagnostic announced Q4 FY26 results with total income increasing 24.7% YoY to Rs.82.2 crore and EBITDA growing 25.7% YoY to Rs.25.15 crore. However, net profit for the quarter declined by 14.1% YoY to Rs.6.16 crore.
May 21 2026 21:02:44
Suraksha Diagnostic Limited
Suraksha Diagnostic declared a final dividend of Rs.0.50 per share (25%) for the financial year 2025-26. The record date for this dividend is August 26, 2026, with payment expected by October 01, 2026, following shareholder approval at the AGM.
May 21 2026 19:26:16
Suraksha Diagnostic Ltd - 544293 - Corporate Action-Board approves Dividend
Suraksha Diagnostic's board recommended a final dividend of ₹0.50 per equity share for FY 2025-26. The record date is August 26, 2026, subject to shareholder approval at the upcoming AGM.
May 21 2026 19:11:12
Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Suraksha Diagnostic will conduct a virtual earnings call on May 22, 2026, at 12:00 PM IST. The company management will discuss its financial performance for Q4 and the full fiscal year 2025-26 with analysts and institutional investors.
May 15 2026 16:32:00
Suraksha Diagnostic Ltd - 544293 - Board Meeting Intimation for Inter-Alia, Considering And Approving Audited (Standalone And Consolidated) Financial Results Of The Company For Quarter And FY 2025-26 And To Consider Recommendation Of Dividend, If Any, On Equity Shares Of Company For FY 2025-26.
Suraksha Diagnostic's Board of Directors is scheduled to meet on May 21, 2026. The agenda includes approving the audited financial results for the quarter and financial year ended March 31, 2026, and considering dividend recommendations.
May 13 2026 17:59:31
Suraksha Diagnostic Limited
SURAKSHA DIAGNOSTIC board will convene on May 21, 2026, to consider its audited yearly financial results for the period ended March 2026. The meeting will also review the proposal for a final dividend.
May 13 2026 17:46:31
Read More